Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey

Shao-quan XIONG; Yu CHEN; Li-juan WANG; Pan-pan LYU; Wan LIAO; Cui WANG; Jian-long KE; Xi ZHU; Jin-yang WANG; Xian-ying SHEN; Guang-ping LI; Li-zhu LIN

doi:10.1007/s11655-019-3184-6

Your Location：

Home >

Browse articles >

Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey

Original Article | Updated：2021-09-01

- Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey
- Chinese Journal of Integrative Medicine Vol. 27, Issue 7, Pages: 502-508(2021)
- Affiliations：
  
  1.Department of Oncology, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu (610000), China
  2.Department of Oncology, Friendship Hospital of Sichuan Provincial People's Hospital, Sichuan Province, Chengdu (610000), China
  3.Department of Oncology, Traditional Chinese Medicine Hospital of Shaanxi Province, Shaanxi Province, Xi'an (710000), China
  4.School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu (610075), China
  5.State Key Laboratory of Characteristic Chinese Drug Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu (611137), China
  6.Department of Oncology, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou (510405), China
- Author bio：
  
  Prof. LIN Li-zhu, E-mail: lizhulin903@21cn.com
- Funds：
- DOI：10.1007/s11655-019-3184-6
  CLC：
- Published：01 July 2021，
  
  Published Online：09 May 2020，
  
  Accepted：28 August 2019
Scan for full text
Shao-quan XIONG, Yu CHEN, Li-juan WANG, et al. Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey. [J]. Chinese Journal of Integrative Medicine 27(7):502-508(2021)
DOI：

Shao-quan XIONG, Yu CHEN, Li-juan WANG, et al. Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey. [J]. Chinese Journal of Integrative Medicine 27(7):502-508(2021) DOI： 10.1007/s11655-019-3184-6.

摘要

Abstract

Objective:

To study the use of Chinese medicine (CM) in cancer patients in southern China.

Methods:

A total of 1

950 cancer patients finished questionnaires in four provinces in southern China. The survey included socio-demographic and clinical characteristics of participants

dosage forms

efficacy

and side effects.

Results:

The study results showed that cancer patients with higher education (>12 years) were more likely to accept the treatment of Chinese herbs. There were 54.61% (1

065 cases) of patients chose Chinese herbs for the initial treatment and 14.46% (282 cases) chose Chinese herbs as monotherapy. Most patients (54.51%

063 cases) continuously used CM for more than 6 months

and a few of them (212 cases) used CM for up to 3 years. All kinds of dosage forms of CM had been used

including CM decoction

CM patent prescription and CM injection. Concerning the efficacy in the view of patients

40.31% (786 cases) believed that it would be effective to take Chinese herbs before they starting the anti-cancer treatment

and the percentage increased to 81.08% after 1-month CM treatment. The effect of Chinese herbs was mainly demonstrated by symptom relief and improvement of quality of life

and 8.31% (162 cases) of patients experienced control of tumor growth and decreased tumor markers. Furthermore

only 14.31% (279 cases) participants reported that they experienced side effects during CM treatment.

Conclusion:

This large scale investigation reflects the current situation of domestic CM usage objectively and comprehensively

which might provide new ways for cancer treatment.

关键词

Keywords

Chinese medicineherbscancerSouth Chinaefficacyside and toxic effect

references

Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017;3:524.

X Sun, X Zhang, JY Nian, J Guo, Y Yin, GL Zhang, et al.Chinese herbal medicine as adjunctive therapy to chemotherapy for breast cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2016;2016:3281968.

J König, K Geschwill, A Lang, FK Tauchert, RD Hofheinz, M Kripp. Use of complementary and alternative medicine in cancer patients: a prospective questionnaire-based study in an oncological outpatient clinic. Oncol Res Treat 2016;39:260-265.

M Berretta, CD Pepa, P Tralongo, A Fulvi, F Martellotta, A Lleshi, et al. Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget 2017;8:24401.

Y Kim, HY Shin, W Moon, SH Cho. Use of complementary and alternative medicine by lung cancer patients in Korea: a qualitative study. Eur J Integr Med 2016;8:266-274.

I Hyodo, N Amano, K Eguchi, M Narabayashi, J Imanishi, M Hirai, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005;23:2645-2654.

YZ Zhu, GB Zhang, GF Zhu. Research progress in mechanism of anti-tumor effects of Chinese medicinal formula. Chin J Exp Prescript (Chin) 2017;23:227-234.

K Eguchi, I Hyodo, H Saeki. Current status of cancer patients'perception of alternative medicine in Japan: a preliminary cross-sectional survey. Support Care Cancer 2000;8:28-32.

Z Xiao, CQ Wang, L Chen, XM Tang, LH Li, NN Li, et al. Has Aidi Injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials. Oncotarget 2017;8:1329.

WY Liu, JW Zhang, XQ Yao, C Jiang, JC He, P Ni, et al.Shenmai Injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution. Acta Pharmacol Sin 2017;38:264.

YT Ling. Traditional Chinese medicine in the treatment of symptoms in patients with advanced cancer. Ann Palliat Med 2013;2:141-152.

WH Chow, P Chang, SC Lee, A Wong, HM Shen, HM Verkooijen. Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singapore 2010;39:129-135.

TG Liu, SQ Xiong, Y Yan, H Zhu, C Yi. Use of Chinese herb medicine in cancer patients: a survey in Southwestern China.Evid Based Complement Alternat Med 2012;2012:769042.

CPD Gülgün, H Kaya. Complementary and alternative medicine use in lung cancer patients and its impact on the quality of life. J Med Sci 2015; 5:41-47.

V Chung, E Wong, J Woo, SV Lo, S Griffiths. Use of traditional Chinese medicine in the Hong Kong special administrative region of China. Altern Complement Med 2007;13:361-367.

P Puataweepong, N Sutheechet, P Ratanamongkol. A survey of complementary and alternative medicine use incancer patients treated with radiotherapy in Thailand. Evid Based Complement Alternat Med 2012;2012:670408.

J Kim, MM Chan. Factors influencing preferences for alternative medicine by Korean Americans. Am J Chin Med 2004;32:321-329.

MA Ferro, A Leis, R Doll, L Chiu, M Chung, MC Barroetavena.The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients. Supp Care Cancer 2007;15:985-992.

I Hyodo, K Eguchi, T Nishina, H Endo, M Tanimizu, I Mikami,, et al. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer 2003;97:2861-2868.

E Chan, M Tan, J Xin, S Sudarsanam, DE Johnson. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opinion Drug Discov Develop 2010;13:50-65.

JCF Leng, F Gany. Traditional Chinese medicine use among Chinese immigrant cancer patients. J Cancer Educ 2014;29:56-61.

MA Richardson, T Sanders, JL Palmer, A Greisinger, SE Singletary. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514.

WR Harlan. East meets West: facing common issues of integrating traditional and Western medicine. J Alternat Complement Med 2002;7 Suppl 1:1-4.

M Oravecz, J Mészáros. Traditional Chinese medicine: theoretical background and its use in China. Orv Het 2012;153:723-731.

B Harriet, K Efrem. Chinese medicine and cancer care. Alternat Ther Health Med 2003;9:38-25.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study

Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini

Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models

Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway

Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice

Related Author

No data

Related Institution

Xiyuan Clinical Medical College, Beijing University of Chinese Medicine

Department of Encephalopathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences

First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine

Institute of Clinical Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Department of Encephalopathy, Botou Traditional Chinese Medicine Hospital of Hebei Province

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰